IBD Patients with Prior Cancer May Run ‘Mild Risk’ of Recurrence with Use of Anti-TNF Therapy

IBD Patients with Prior Cancer May Run ‘Mild Risk’ of Recurrence with Use of Anti-TNF Therapy
Research into the risk of new cancers in inflammatory bowel disease (IBD) patients treated for a prior malignancy and undergoing anti-tumor necrosis factor (anti-TNF) therapy supported the treatment’s use, but found a slight risk of incident cancer existed and needed to be taken into account. The study, titled “Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *